YD Bio Limited (YDES)
$5.79-1.53%Close
BUYCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $410M
- Beta
- -0.12
- P/E (TTM)
- -51.25
- Short % float
- 3.01%
- Days to cover
- 1.0
- SI change
- +223.2%
- 1W
- -25.86%
- 1M
- +47.33%
- vs SPY 1W
- -27.42%
- vs SPY 1M
- +45.56%
Industry peers
FMP comparable companies · ranked by market cap
- DAWNDay One Biopharmaceuticals, Inc.$2.2B$21.53
- MRVIBUYMaravai LifeSciences Holdings, Inc.$2.2BCRISISQ -2$7.90-2.96%
- VIRBUYVir Biotechnology, Inc.$1.9BRECOVERYQ 13$11.17-3.47%
- TYRASELLTyra Biosciences, Inc.$1.2BCRISISQ 5$20.43-2.06%
- BTXBlackRock Technology and Private Equity Term Trust$1.1B$9.22
- GLUESELLMonte Rosa Therapeutics, Inc.$887MCRISISQ 7$10.50+1.47%
- TBPHBUYTheravance Biopharma Inc$883MBULLQ -1$17.03+0.00%
- GERNSELLGeron Corporation$770MRECOVERYQ 11$1.20+1.67%
- PRMEBUYPrime Medicine, Inc.$538MRECOVERYQ -7$2.98-8.21%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 5
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-267.1%
REV YoY-
ROE-445.1%
EPS YoY-
ROA-60.3%
GROSS-7
OP-883
NET-1393
[VALUATION]
P/E TTM-51.25
P/E FWD-
SECTOR PE20.47
INDUSTRY PE13.95
P/B-143.69
P/FCF-
EV/EBITDA-53.02
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO5.88
ND/EBITDA-
BETA-0.12
